"Not many think the Fed is going to hike tomorrow, but whether they change the language to get a little more hawkish, there’s been conversation around that," said Walter Todd, chief investment officer at Greenwood Capital in Greenwood, South Carolina. "The Bank of Japan is a whole other issue unto itself ... Given the level of uncertainty around those two meetings, I just think people are kind of biding their time. Tobira shares soared more than 700 percent, while Allergan shares fell 2.7 percent.Shares of Gilead Sciences , which is also developing drugs for NASH, rose 3.5 percent and gave the biggest boost to the S&P and the Nasdaq.Wells Fargo shares rose 1.2 percent after the bank's chief executive weathered criticism as he testified before a U.S. Senate panel.Energy shares were the worst performing group, falling 0.8 percent. Exxon fell 1.5 percent.

Source: The Star September 20, 2016 20:26 UTC